Get started

Agenus Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

AGEN chart

Key stats

Market capitalization
296.46MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.8166USD
Net income
−220.074MUSD
Revenue
98.024MUSD
Shares float
363.505M
Beta
2.18

About Agenus Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Garo H. Armen
Website
agenusbio.com
Headquarters
Lexington
Employees (FY)
533
Founded
1994
ISIN
US00847G7051
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Ideas

AGEN | Agenus Inc. Healthcare | Biotechnology | USA | NASDAQ 📈 Technical Chart Patterns & Trend Analysis 📉 Identifying potential trading opportunities based on trend analysis: After forming Bullish divergence the price charts signals a potential trend reversal, indicating a shift from a downtrend to a possible uptrend.
Long
by shah_baz
AGENUS Stock Chart Fibonacci Analysis 071023 Trading Idea 1) Find a FIBO slingshot 2) Check FIBO 61.80% level 3) Entry Point > 1.7/61.80% Chart time frame : B A) 15 min(1W-3M) B) 1 hr(3M-6M) C) 4 hr(6M-1year) D) 1 day(1-3years) Stock progress : A A) Keep rising over 61.80% resistance B) 61.80% resistance C) Hit the bottom D) Hit the top
by fibonacci6180
AGENUS going back inAgenus NASDAQ:AGEN is a stock that I have not followed since they were forced (unfairly) by the FDA to pull their NDA for balstilimab. However recently price action has started to look favourable and this is in conjuction with ASCO where the company is presenting clinical data from 2 trials.
Long
by et20tradeview
Gap Fill + Great earnings reportThe earnings report is expected to be good and therefore i think there will at least be a gap fill up to 5. Looking at the macd it also looks like we are gonna have a green crossover to the upwards movement. I wouldsay bullish. I could be completely wrong and this should be taken with a grain of s
Long
by MasterTraderOne
AGEN Daily TimeframeSNIPER STRATEGY (new version) It works ALMOST ON ANY CHART. It produces Weak, Medium and Strong signals based on consisting elements. NOT ALL TARGETS CAN BE ACHIEVED, let's make that clear. TARGETS OR ENTRY PRICES ARE STRONG SUPPORT AND RESISTANCE LEVELS. ENTRY PRICE BLACK COLOR TARGETS
Short
by hadimozayan
AGEN digging through the CratesAGEN hasn't done this in years...what? It hasn't sustained these levels for any meaningful amount of time. I did a quick fib retracement using those 2017 highs as the upper anchor and you can see what has revealed itself. The 236 area is a key pivot. Most of the time it has acted as a resistance pi
by PennyStocks101

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers